Details for New Drug Application (NDA): 018621
✉ Email this page to a colleague
NDA 018621 describes NITRO-BID, which is a drug marketed by Sanofi Aventis Us and is included in two NDAs. Additional details are available on the NITRO-BID profile page.
The generic ingredient in NITRO-BID is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
The generic ingredient in NITRO-BID is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 018621
| Tradename: | NITRO-BID |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | nitroglycerin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018621
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | Jan 5, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
